tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CYCN Stock Latest News

Cyclerion Therapeutics Appoints New CEO Regina Graul
Company AnnouncementsCyclerion Therapeutics Appoints New CEO Regina Graul
2M ago
8K
CYCN
Cyclerion Therapeutics appoints Regina Graul as CEO
PremiumThe Fly
Cyclerion Therapeutics appoints Regina Graul as CEO
2M ago
CYCN
Regina Graul, Ph.D., Promoted to Chief Executive Officer
PremiumPress Releases
Regina Graul, Ph.D., Promoted to Chief Executive Officer
2M ago
CYCN
Cyclerion Therapeutics appoints Graul as President
PremiumThe Fly
Cyclerion Therapeutics appoints Graul as President
10M ago
CYCN
Cyclerion Therapeutics, Tisento close asset purchase agreement
PremiumThe Fly
Cyclerion Therapeutics, Tisento close asset purchase agreement
1y ago
CYCN
Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets
PremiumPress ReleasesTisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets
1y ago
CYCN
Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement
Premium
Press Releases
Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement
1y ago
CYCN
Cyclerion Announces Reverse Stock Split
Premium
Press Releases
Cyclerion Announces Reverse Stock Split
1y ago
CYCN
Cyclerion Announces Corporate Updates and Q1 2023 Financial Results
PremiumPress Releases
Cyclerion Announces Corporate Updates and Q1 2023 Financial Results
1y ago
CYCN
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
PremiumPress Releases
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
1y ago
CYCN
Cyclerion Therapeutics Enters into Exclusive Negotiation Period and Binding Equity Investment Agreement
PremiumPress Releases
Cyclerion Therapeutics Enters into Exclusive Negotiation Period and Binding Equity Investment Agreement
1y ago
CYCN
Cyclerion enters negotiation period, binding equity investment agreement
PremiumThe Fly
Cyclerion enters negotiation period, binding equity investment agreement
1y ago
CYCN
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1y ago
UBX
CYCN
Cyclerion Therapeutics receives U.S. FDA orphan drug designation for zagociguat
Premium
The Fly
Cyclerion Therapeutics receives U.S. FDA orphan drug designation for zagociguat
1y ago
CYCN
Cyclerion Therapeutics Receives U.S. FDA Orphan Drug Designation for Zagociguat for the Treatment of Mitochondrial Diseases
Premium
Press Releases
Cyclerion Therapeutics Receives U.S. FDA Orphan Drug Designation for Zagociguat for the Treatment of Mitochondrial Diseases
1y ago
CYCN
Cyclerion Therapeutics treatment of mitochondrial disease gets orphan status
PremiumThe Fly
Cyclerion Therapeutics treatment of mitochondrial disease gets orphan status
2y ago
CYCN
Cyclerion Reports Corporate Update and Full Year 2022 Financial Results
PremiumPress Releases
Cyclerion Reports Corporate Update and Full Year 2022 Financial Results
2y ago
CYCN
Cyclerion Concludes Unsolicited Proposal Is Not in The Best Interest of The Company
PremiumPress Releases
Cyclerion Concludes Unsolicited Proposal Is Not in The Best Interest of The Company
2y ago
CYCN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2y ago
AGTC
CYCN
Cyclerion Announces Mitochondrial Disease-Focused Corporate Strategy
PremiumPress ReleasesCyclerion Announces Mitochondrial Disease-Focused Corporate Strategy
2y ago
CYCN
Cyclerion Announces CY6463 Clinical Pipeline Progress and Second Quarter 2022 Financial Results
Premium
Press Releases
Cyclerion Announces CY6463 Clinical Pipeline Progress and Second Quarter 2022 Financial Results
2y ago
CYCN
Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation
Premium
Press Releases
Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation
2y ago
CYCN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >